Back to Search
Start Over
Retinal nerve fiber layer thickness predicts CSF amyloid/tau before cognitive decline.
- Source :
-
PloS one [PLoS One] 2020 May 29; Vol. 15 (5), pp. e0232785. Date of Electronic Publication: 2020 May 29 (Print Publication: 2020). - Publication Year :
- 2020
-
Abstract
- Background: Alzheimer's disease (AD) pathology precedes symptoms and its detection can identify at-risk individuals who may benefit from early treatment. Since the retinal nerve fiber layer (RNFL) is depleted in established AD, we tested whether its thickness can predict whether cognitively healthy (CH) individuals have a normal or pathological cerebrospinal fluid (CSF) Aß42 (A) and tau (T) ratio.<br />Methods: As part of an ongoing longitudinal study, we enrolled CH individuals, excluding those with cognitive impairment and significant ocular pathology. We classified the CH group into two sub-groups, normal (CH-NAT, n = 16) or pathological (CH-PAT, n = 27), using a logistic regression model from the CSF AT ratio that identified >85% of patients with a clinically probable AD diagnosis. Spectral-domain optical coherence tomography (OCT) was acquired for RNFL, ganglion cell-inner plexiform layer (GC-IPL), and macular thickness. Group differences were tested using mixed model repeated measures and a classification model derived using multiple logistic regression.<br />Results: Mean age (± standard deviation) in the CH-PAT group (n = 27; 75.2 ± 8.4 years) was similar (p = 0.50) to the CH-NAT group (n = 16; 74.1 ± 7.9 years). Mean RNFL (standard error) was thinner in the CH-PAT group by 9.8 (2.7) μm; p < 0.001. RNFL thickness classified CH-NAT vs. CH-PAT with 87% sensitivity and 56.3% specificity.<br />Conclusions: Our retinal data predict which individuals have CSF biomarkers of AD pathology before cognitive deficits are detectable with 87% sensitivity. Such results from easy-to-acquire, objective and non-invasive measurements of the RNFL merit further study of OCT technology to monitor or screen for early AD pathology.<br />Competing Interests: The authors have declared that no competing interests exist.
- Subjects :
- Aged
Aged, 80 and over
Alzheimer Disease cerebrospinal fluid
Alzheimer Disease diagnostic imaging
Alzheimer Disease pathology
Amyloid beta-Peptides cerebrospinal fluid
Amyloidosis cerebrospinal fluid
Amyloidosis diagnostic imaging
Amyloidosis genetics
Amyloidosis pathology
Biomarkers cerebrospinal fluid
Cognitive Dysfunction cerebrospinal fluid
Cognitive Dysfunction diagnostic imaging
Cognitive Dysfunction pathology
Female
Humans
Male
Middle Aged
Nerve Fibers metabolism
Nerve Fibers pathology
Optic Disk diagnostic imaging
Optic Disk metabolism
Optic Disk pathology
Retina diagnostic imaging
Retina metabolism
Retina pathology
Retinal Ganglion Cells metabolism
Retinal Ganglion Cells pathology
Tomography, Optical Coherence
tau Proteins cerebrospinal fluid
Alzheimer Disease genetics
Amyloid beta-Peptides genetics
Cognitive Dysfunction genetics
tau Proteins genetics
Subjects
Details
- Language :
- English
- ISSN :
- 1932-6203
- Volume :
- 15
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- PloS one
- Publication Type :
- Academic Journal
- Accession number :
- 32469871
- Full Text :
- https://doi.org/10.1371/journal.pone.0232785